BackEagle Pharmaceuticals Overview
Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Discounted Cash Flow

DCF Analysis for EGRX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$12.59

Current Fair Value

$12.59
1946.8% Upside

Undervalued by 1946.8% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading